News Center
Chen Heping, member of the leading Party group and deputy director of Jiangsu Drug Administration, investigated Jiangsu Lekai Biotechnology Co., LTD
2024-10-21
From October 17 to 18, Chen Heping, member of the Leading Party group and deputy director of the Drug Administration of Jiangsu Province, visited Zhangjiagang to investigate the development of medical device industry. Wang Linlin, Director of Suzhou Inspection Branch and Director of Suzhou Branch Center of Evaluation and Verification of Drug Administration of Jiangsu Province, Party Secretary and Director of Market Supervision and Administration of Zhangjiagang City,
Chen Heping and his party made a field investigation of Maidi Industrial Innovation Port and Zhangjiagang Medical Device Inspection, Testing and R&D Incubation Center, and listened to the development planning of the park, the progress of carrier construction and the settlement of medical device enterprises in detail.
The research team has visited Suzhou Aide Technology Development Co., LTD., Jiangsu Lekai Biotechnology Co., LTD., in-depth understanding of enterprise development status, business layout, innovative research and development and other aspects of the situation, "face to face" for medical device manufacturers to take the patient, and enterprises in the application of innovative products, change registration and other problems to give professional guidance.
At the exchange forum, the research team listened to the development report of Zhangjiagang Medical Device high-tech Industrial Park. The Party Branch of Medical Device Production Supervision of Jiangsu Drug Administration, the Party Branch of Suzhou Inspection Branch of Jiangsu Drug Administration, the Third Party Branch of Zhangjiagang Market Supervision and Administration, and the Party Branch of Economic Service Bureau of Metallurgical Industrial Park (Jin-feng Town) signed a four-level cooperation agreement on Party Construction and Joint Construction, and exchanged work experience around Party construction and business. We will promote the deep integration of Party building and professional work.
A Brilliant Recap | Jiangsu Lekai Concludes with a Resounding Success at COA 2025!
2025-11-19
From November 12 to 16, 2025, the 24th Orthopaedic Academic Conference of the Chinese Medical Association and the 17th COA Academic Congress were grandly held at the Tianjin National Convention and Exhibition Center. Focusing on the theme "Intelligent Orthopaedics · Exploring Future Frontiers," the conference attracted tens of thousands of orthopaedic professionals from across the country to participate in this grand event.
Jiangsu Lekai "Collagen" obtained ISO 13485:2016 standard management system certification!
2025-02-13
Jiangsu Lekai Biotechnology Co., LTD. (hereinafter referred to as "Jiangsu Lekai") "collagen raw material" quality management system in accordance with: ISO 13485:2016 standard, obtained the management system certification certificate, certificate No. : C718165.
2024-12-25
Orthopedic colleagues from all over the country gathered in Wuhan to exchange scientific research, exchange techniques, explore and promote the innovation and transformation of the field of orthopedics in China.
Copyright©2023 Jiangsu Lekai Biotechnology Co., Ltd. Powered by www.300.cn SEO